The 2020 updates to the World Health Organisation (WHO) guidelines shifted the global standard of care for drug-resistant TB in a number of important ways.
Our publication, An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis, details these shifts and other important information about the new global standard of care for drug-resistant TB, and provides messaging and strategies activists can use to advocate for improved access to WHO-recommended regimens and the new and repurposed medicines contained therein.
Our guide unpacks the latest WHO guidelines and supporting evidence bases, and breaks down what activists and communities affected by drug-resistant TB need to know to take action, overcome resistance, and hold governments and other actors accountable for ensuring equitable access to the best available standard of care for drug-resistant TB.
[link url="https://www.treatmentactiongroup.org/publication/an-activists-guide-to-treatment-for-drug-resistant-tuberculosis/"]Treatment Action Group material[/link]
[link url="https://www.treatmentactiongroup.org/wp-content/uploads/2020/07/activists_guide_dr_tb_treatment_2020.pdf"]Guidelines[/link]